PMH3 Olanzapine Long-Acting Injection for Schizophrenia- An Evaluation of Patient Functioning During 24 Weeks of Maintenance Therapy
Abstract
Authors
D. Novick H. Anand H. Ascher-Svanum J. Haro J. Bertsch Z. Cui H. Detke D. Mcdonnell W. Montgomery